0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
AI In Oncology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8F15414
Home | Market Reports | Health| Health Conditions| Cancer
Global AI In Oncology Market Insights Forecast to 2029
BUY CHAPTERS

AI In Oncology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8F15414
Report
December 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI In Oncology - Market Size

In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022.

AI In Oncology - Market

AI In Oncology - Market

The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
The global market for AI In Oncology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.131%, including software, hardware and services.

Report Scope

This report aims to provide a comprehensive presentation of the global market for AI In Oncology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI In Oncology by region & country, by Type, and by Application.
The AI In Oncology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Oncology.
Market Segmentation

Scope of AI In Oncology - Market Report

Report Metric Details
Report Name AI In Oncology - Market
Accounted market size in 2022 US$ billion to US$ 1.7 billion
Base Year 2022
Segment by Type:
  • Software Solutions
  • Hardware
  • Services
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI, Median Technologies, Path AI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of AI In Oncology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of AI In Oncology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of AI In Oncology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the AI In Oncology - Market report?

Ans: The main players in the AI In Oncology - Market are Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI, Median Technologies, Path AI

What are the Application segmentation covered in the AI In Oncology - Market report?

Ans: The Applications covered in the AI In Oncology - Market report are Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others

What are the Type segmentation covered in the AI In Oncology - Market report?

Ans: The Types covered in the AI In Oncology - Market report are Software Solutions, Hardware, Services

Recommended Reports

AI Cancer Diagnostics

AI Healthcare Platforms

AI Oncology Applications

1 Market Overview
1.1 AI In Oncology Product Introduction
1.2 Global AI In Oncology Market Size Forecast
1.3 AI In Oncology Market Trends & Drivers
1.3.1 AI In Oncology Industry Trends
1.3.2 AI In Oncology Market Drivers & Opportunity
1.3.3 AI In Oncology Market Challenges
1.3.4 AI In Oncology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI In Oncology Players Revenue Ranking (2023)
2.2 Global AI In Oncology Revenue by Company (2019-2024)
2.3 Key Companies AI In Oncology Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI In Oncology Product Offered
2.5 Key Companies Time to Begin Mass Production of AI In Oncology
2.6 AI In Oncology Market Competitive Analysis
2.6.1 AI In Oncology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI In Oncology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software Solutions
3.1.2 Hardware
3.1.3 Services
3.2 Global AI In Oncology Sales Value by Type
3.2.1 Global AI In Oncology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI In Oncology Sales Value, by Type (2019-2030)
3.2.3 Global AI In Oncology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Breast Cancer
4.1.2 Lung Cancer
4.1.3 Prostate Cancer
4.1.4 Colorectal Cancer
4.1.5 Brain Tumor
4.1.6 Others
4.2 Global AI In Oncology Sales Value by Application
4.2.1 Global AI In Oncology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI In Oncology Sales Value, by Application (2019-2030)
4.2.3 Global AI In Oncology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI In Oncology Sales Value by Region
5.1.1 Global AI In Oncology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI In Oncology Sales Value by Region (2019-2024)
5.1.3 Global AI In Oncology Sales Value by Region (2025-2030)
5.1.4 Global AI In Oncology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI In Oncology Sales Value, 2019-2030
5.2.2 North America AI In Oncology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI In Oncology Sales Value, 2019-2030
5.3.2 Europe AI In Oncology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI In Oncology Sales Value, 2019-2030
5.4.2 Asia Pacific AI In Oncology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI In Oncology Sales Value, 2019-2030
5.5.2 South America AI In Oncology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI In Oncology Sales Value, 2019-2030
5.6.2 Middle East & Africa AI In Oncology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI In Oncology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI In Oncology Sales Value
6.3 United States
6.3.1 United States AI In Oncology Sales Value, 2019-2030
6.3.2 United States AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI In Oncology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI In Oncology Sales Value, 2019-2030
6.4.2 Europe AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI In Oncology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI In Oncology Sales Value, 2019-2030
6.5.2 China AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI In Oncology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI In Oncology Sales Value, 2019-2030
6.6.2 Japan AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI In Oncology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI In Oncology Sales Value, 2019-2030
6.7.2 South Korea AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI In Oncology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI In Oncology Sales Value, 2019-2030
6.8.2 Southeast Asia AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI In Oncology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI In Oncology Sales Value, 2019-2030
6.9.2 India AI In Oncology Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI In Oncology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Azra AI
7.1.1 Azra AI Profile
7.1.2 Azra AI Main Business
7.1.3 Azra AI AI In Oncology Products, Services and Solutions
7.1.4 Azra AI AI In Oncology Revenue (US$ Million) & (2019-2024)
7.1.5 Azra AI Recent Developments
7.2 IBM
7.2.1 IBM Profile
7.2.2 IBM Main Business
7.2.3 IBM AI In Oncology Products, Services and Solutions
7.2.4 IBM AI In Oncology Revenue (US$ Million) & (2019-2024)
7.2.5 IBM Recent Developments
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Profile
7.3.2 Siemens Healthineers Main Business
7.3.3 Siemens Healthineers AI In Oncology Products, Services and Solutions
7.3.4 Siemens Healthineers AI In Oncology Revenue (US$ Million) & (2019-2024)
7.3.5 Intel Recent Developments
7.4 Intel
7.4.1 Intel Profile
7.4.2 Intel Main Business
7.4.3 Intel AI In Oncology Products, Services and Solutions
7.4.4 Intel AI In Oncology Revenue (US$ Million) & (2019-2024)
7.4.5 Intel Recent Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Profile
7.5.2 GE Healthcare Main Business
7.5.3 GE Healthcare AI In Oncology Products, Services and Solutions
7.5.4 GE Healthcare AI In Oncology Revenue (US$ Million) & (2019-2024)
7.5.5 GE Healthcare Recent Developments
7.6 NVIDIA
7.6.1 NVIDIA Profile
7.6.2 NVIDIA Main Business
7.6.3 NVIDIA AI In Oncology Products, Services and Solutions
7.6.4 NVIDIA AI In Oncology Revenue (US$ Million) & (2019-2024)
7.6.5 NVIDIA Recent Developments
7.7 Digital Diagnostics Inc.
7.7.1 Digital Diagnostics Inc. Profile
7.7.2 Digital Diagnostics Inc. Main Business
7.7.3 Digital Diagnostics Inc. AI In Oncology Products, Services and Solutions
7.7.4 Digital Diagnostics Inc. AI In Oncology Revenue (US$ Million) & (2019-2024)
7.7.5 Digital Diagnostics Inc. Recent Developments
7.8 Concert.AI
7.8.1 Concert.AI Profile
7.8.2 Concert.AI Main Business
7.8.3 Concert.AI AI In Oncology Products, Services and Solutions
7.8.4 Concert.AI AI In Oncology Revenue (US$ Million) & (2019-2024)
7.8.5 Concert.AI Recent Developments
7.9 Median Technologies
7.9.1 Median Technologies Profile
7.9.2 Median Technologies Main Business
7.9.3 Median Technologies AI In Oncology Products, Services and Solutions
7.9.4 Median Technologies AI In Oncology Revenue (US$ Million) & (2019-2024)
7.9.5 Median Technologies Recent Developments
7.10 Path AI
7.10.1 Path AI Profile
7.10.2 Path AI Main Business
7.10.3 Path AI AI In Oncology Products, Services and Solutions
7.10.4 Path AI AI In Oncology Revenue (US$ Million) & (2019-2024)
7.10.5 Path AI Recent Developments
8 Industry Chain Analysis
8.1 AI In Oncology Industrial Chain
8.2 AI In Oncology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI In Oncology Sales Model
8.5.2 Sales Channel
8.5.3 AI In Oncology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. AI In Oncology Market Trends
    Table 2. AI In Oncology Market Drivers & Opportunity
    Table 3. AI In Oncology Market Challenges
    Table 4. AI In Oncology Market Restraints
    Table 5. Global AI In Oncology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global AI In Oncology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies AI In Oncology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies AI In Oncology Product Type
    Table 9. Key Companies Time to Begin Mass Production of AI In Oncology
    Table 10. Global AI In Oncology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global AI In Oncology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global AI In Oncology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global AI In Oncology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global AI In Oncology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global AI In Oncology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global AI In Oncology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global AI In Oncology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global AI In Oncology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global AI In Oncology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global AI In Oncology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global AI In Oncology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global AI In Oncology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global AI In Oncology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global AI In Oncology Sales Value by Region (2019-2024) & (%)
    Table 27. Global AI In Oncology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions AI In Oncology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions AI In Oncology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions AI In Oncology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Azra AI Basic Information List
    Table 32. Azra AI Description and Business Overview
    Table 33. Azra AI AI In Oncology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in AI In Oncology Business of Azra AI (2019-2024)
    Table 35. Azra AI Recent Developments
    Table 36. IBM Basic Information List
    Table 37. IBM Description and Business Overview
    Table 38. IBM AI In Oncology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in AI In Oncology Business of IBM (2019-2024)
    Table 40. IBM Recent Developments
    Table 41. Siemens Healthineers Basic Information List
    Table 42. Siemens Healthineers Description and Business Overview
    Table 43. Siemens Healthineers AI In Oncology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in AI In Oncology Business of Siemens Healthineers (2019-2024)
    Table 45. Siemens Healthineers Recent Developments
    Table 46. Intel Basic Information List
    Table 47. Intel Description and Business Overview
    Table 48. Intel AI In Oncology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in AI In Oncology Business of Intel (2019-2024)
    Table 50. Intel Recent Developments
    Table 51. GE Healthcare Basic Information List
    Table 52. GE Healthcare Description and Business Overview
    Table 53. GE Healthcare AI In Oncology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in AI In Oncology Business of GE Healthcare (2019-2024)
    Table 55. GE Healthcare Recent Developments
    Table 56. NVIDIA Basic Information List
    Table 57. NVIDIA Description and Business Overview
    Table 58. NVIDIA AI In Oncology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in AI In Oncology Business of NVIDIA (2019-2024)
    Table 60. NVIDIA Recent Developments
    Table 61. Digital Diagnostics Inc. Basic Information List
    Table 62. Digital Diagnostics Inc. Description and Business Overview
    Table 63. Digital Diagnostics Inc. AI In Oncology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in AI In Oncology Business of Digital Diagnostics Inc. (2019-2024)
    Table 65. Digital Diagnostics Inc. Recent Developments
    Table 66. Concert.AI Basic Information List
    Table 67. Concert.AI Description and Business Overview
    Table 68. Concert.AI AI In Oncology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in AI In Oncology Business of Concert.AI (2019-2024)
    Table 70. Concert.AI Recent Developments
    Table 71. Median Technologies Basic Information List
    Table 72. Median Technologies Description and Business Overview
    Table 73. Median Technologies AI In Oncology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in AI In Oncology Business of Median Technologies (2019-2024)
    Table 75. Median Technologies Recent Developments
    Table 76. Path AI Basic Information List
    Table 77. Path AI Description and Business Overview
    Table 78. Path AI AI In Oncology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in AI In Oncology Business of Path AI (2019-2024)
    Table 80. Path AI Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. AI In Oncology Downstream Customers
    Table 84. AI In Oncology Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. AI In Oncology Product Picture
    Figure 2. Global AI In Oncology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 4. AI In Oncology Report Years Considered
    Figure 5. Global AI In Oncology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI In Oncology Revenue in 2023
    Figure 7. AI In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Software Solutions Picture
    Figure 9. Hardware Picture
    Figure 10. Services Picture
    Figure 11. Global AI In Oncology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global AI In Oncology Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Breast Cancer
    Figure 14. Product Picture of Lung Cancer
    Figure 15. Product Picture of Prostate Cancer
    Figure 16. Product Picture of Colorectal Cancer
    Figure 17. Product Picture of Brain Tumor
    Figure 18. Product Picture of Others
    Figure 19. Global AI In Oncology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global AI In Oncology Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America AI In Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe AI In Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific AI In Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America AI In Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa AI In Oncology Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa AI In Oncology Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions AI In Oncology Sales Value (%), (2019-2030)
    Figure 32. United States AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 38. China AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 40. China AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 50. India AI In Oncology Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India AI In Oncology Sales Value by Type (%), 2023 VS 2030
    Figure 52. India AI In Oncology Sales Value by Application (%), 2023 VS 2030
    Figure 53. AI In Oncology Industrial Chain
    Figure 54. AI In Oncology Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart